Talk:Joseph Jimenez

This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Articles for creation This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC articles This article was accepted on 17 March 2012 by reviewer Aaron Booth (talk · contribs). Biography: Science and Academia This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles This article is supported by the science and academia work group. United States Mid‑importance This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States articles Mid This article has been rated as Mid-importance on the project's importance scale. Business Mid‑importance This article is within the scope of WikiProject Business, a collaborative effort to improve the coverage of business articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.BusinessWikipedia:WikiProject BusinessTemplate:WikiProject BusinessWikiProject Business articles Mid This article has been rated as Mid-importance on the project's importance scale.

It is requested that an image or photograph be included in this article to improve its quality. Please replace this template with a more specific media request template where possible. The Free Image Search Tool or Openverse Creative Commons Search may be able to locate suitable images on Flickr and other web sites.

Upload

Hi, I'm Katya – a social media manager at Novartis. I'm aware of WP:COI and thus would like to raise to the community some portions of this article that I think could be improved.

It looks like Section 3.1 was simply copied and pasted in its entirety from the article on Novartis.

I'm not sure if this section should be here, for a number of reasons. The duplication seems to be redundant (especially as there's an extensive record of this information on the main Novartis article). Also, most of these controversies happened before Joseph Jimenez became CEO in 2010. Some of them even happened before he joined Novartis in 2007.

The last part of this section (3.1.6) has actually been cut from the main Novartis article. The court case is ongoing, so there’s no solid story yet. In the interests of NPOV, wouldn’t it be better to wait until the case is settled one way or the other before writing about it?

Finally, the Conflicts and Criticisms section is much, much larger than the rest of the article. Doesn't this constitute Undue Weight?

For the reasons listed above I’d recommend to remove the section 3.1. Please let me know what you think. Katya Reck (talk) 14:57, 6 December 2013 (UTC)[reply]

Hello. OMG, the section 3.1 is so wrong here. You are absolutely right, I deleted it. Regards --KurtR (talk) 22:30, 26 December 2013 (UTC)[reply]

This edit request by an editor with a conflict of interest has now been answered.

Can you please update the "Novartis" section in the article to add, "Jimenez stepped down from the Board of Directors of startup uBiome in April 2019 to run his own venture fund."^[1][2][3][4] Naomi at Ruder Finn (talk) 19:36, 17 June 2019 (UTC)[reply]

@Naomi at Ruder Finn:  Done –MJL ‐Talk‐^☖ 20:11, 17 June 2019 (UTC)[reply]

Date of birth is needed.--109.252.91.11 (talk) 05:14, 8 November 2020 (UTC)[reply]

This edit request by an editor with a conflict of interest was declined.

Joseph Jimenez serves on the boards of multiple companies and it would be great to create a new section called 'Board positions' after the 'Novartis' section. The information about his board positions is provided below, along with citations for each.

Can you please move the sentence "Jimenez joined the board of directors at General Motors on June 9, 2015^[1]." from the 'Novartis' section to the beginning of the 'Board positions' section?

Can you please add the below to the 'Board positions' section after the General Motors sentence:

Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director^[2]. He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company^[3][4].

Isabelle at Ruder Finn (talk) 17:15, 2 August 2022 (UTC)[reply]

 Not done: Denied due to a lack of independent and reliable sourcing, pursuant to WP:RS. Also, it is unnecessary to create a new section for his board positions. That can go into the article's Career section. Quetstar (talk) 17:51, 2 August 2022 (UTC)[reply]

Thank you for your feedback. I have provided alternative references from reputable third party sources for each of the Board position entries below. Please let me know if this works for you and can be incorporated into the article. Ok to have it as part of the Career section as you recommended.

Jimenez joined the board of directors at General Motors on June 9, 2015.

Source: https://www.fiercepharma.com/pharma/p-g-investors-wish-for-ceo-joe-jimenez-as-outgoing-novartis-chief-joins-board

Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director.

Source: https://www.fiercepharma.com/pharma/p-g-investors-wish-for-ceo-joe-jimenez-as-outgoing-novartis-chief-joins-board

He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company.

Source: https://www.biospace.com/article/releases/century-therapeutics-expands-board-of-directors-with-key-appointments/

Source: https://www.bloomberg.com/profile/company/1830598D:US?sref=5GnwNQsL Isabelle at Ruder Finn (talk) 13:43, 3 August 2022 (UTC)[reply]

This edit request by an editor with a conflict of interest has now been answered.

Per the feedback provided above by Quetstar^[1], I have revised the request and since I haven't heard back from Quetstar for a couple of weeks, I would like to re-submit this request to the general Talk page in the hopes that some other editor will review and publish these edits.

Can you please add the following information to the Careers section:

Jimenez joined the board of directors at General Motors on June 9, 2015^[2].

Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director^[3].

He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company^[4][5].

(You can reopen a request by removing the |D or |P from the end of the {{edit COI}}. We're unlikely to see it if it's still marked as closed, because it won't show up on the list of still-open ones.)

 Done ℰmi1y_⧼T·C⧽ 20:21, 21 November 2022 (UTC)[reply]

Isabelle at Ruder Finn (talk) 18:03, 19 August 2022 (UTC)[reply]